AVITA Medical Overview
AVITA Medical (RCEL) has a ROE of 154.76%, above the sector sector average of -5.84%.
Get informed when a big investor buys or sells
+ Follow154.76%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, RCEL shows a ROE of 154.76%. That is above the sector sector average of -5.84%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about -5.84%. AVITA Medical is at 154.76%, which is higher that average. That is roughly 2747.8% above the sector mean. Use the comparison chart on this page to see how RCEL stacks up against individual peers as well.
Check the historical chart to see whether RCEL's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare AVITA Medical with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has AVITA Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 154.76%) with ownership activity and broader fundamentals.
